Strengthening Neurological Care: Enhancing Access and Capacity in the Middle East & Africa Parkinson’s Disease Market

The Middle East & Africa Parkinson’s disease market is progressing steadily, supported by growing healthcare investments, rising disease awareness, and the gradual expansion of neurology care services. Countries such as Saudi Arabia, the United Arab Emirates (UAE), South Africa, and Egypt are leading regional efforts to improve diagnosis and management of Parkinson’s through hospital infrastructure upgrades, physician training, and improved availability of essential medications. Although disparities in healthcare access and limited specialist availability continue to challenge parts of the region, the ongoing implementation of national health strategies and the participation of international pharmaceutical firms are strengthening Parkinson’s disease treatment ecosystems. Furthermore, collaborations between global research organizations and local health ministries are paving the way for improved disease understanding, earlier intervention, and better patient outcomes across the Middle East and Africa.

Key Market Findings

• Increasing Awareness and Expanding Diagnostic Infrastructure

Rising awareness of neurodegenerative disorders is driving earlier detection of Parkinson’s disease across the Middle East and Africa. Urban centers such as Dubai, Riyadh, Johannesburg, and Cairo are witnessing improved diagnostic capabilities with the adoption of advanced imaging tools and specialized neurology departments. Advocacy groups and regional neurological associations are actively working to destigmatize the disease and promote public education about early symptoms and treatment options.

• Growing Availability of Modern Therapeutic Options

The region is seeing a broader introduction of advanced dopaminergic therapies, including extended-release levodopa, MAO-B inhibitors, and COMT inhibitors, through the efforts of multinational pharmaceutical companies such as AbbVie, Novartis, and Boehringer Ingelheim. Parallel import mechanisms and government procurement programs are further helping to improve access to essential Parkinson’s drugs in public hospitals and clinics, particularly in Gulf Cooperation Council (GCC) countries.

• Government-Led Healthcare Reforms Supporting Neurology Care

Several Middle Eastern and African nations are prioritizing neurological disorders under their national healthcare transformation plans. Initiatives such as Saudi Vision 2030, the UAE National Strategy for Wellbeing, and South Africa’s National Health Insurance (NHI) framework are expanding access to chronic disease management, including Parkinson’s. These programs emphasize equitable access to medication, specialized care, and rehabilitation services, driving steady improvements in long-term patient management.

Companies Covered

Novartis AG, AbbVie Inc., Acadia Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc (GSK), and emerging players/startups. (LIST NOT EXHAUSTIVE)

1. Middle East and Africa Market Methodology and Scope

2. Middle East and Africa Market Definition and Overview

3. Middle East and Africa Market Executive Summary

4. Middle East and Africa Market Dynamics

   1. Market Drivers
   2. Market Restraints
   3. Emerging Opportunities

5. Middle East and Africa Market Industry Analysis

   1. Porter's Five Forces Analysis
   2. Regulatory Analysis
   3. SWOT Analysis
   4. Sustainability Analysis
   5. Unmet Needs and Gaps
   6. Pricing Analysis and Price Dynamics
   7. Latest Developments and Breakthroughs

6. Market Segmentation – By Drug Class

   1. Dopamine Agonists
   2. MAO-B Inhibitors
   3. COMT Inhibitors
   4. Adenosine A2A Receptor Antagonists
   5. Amantadine & Derivatives
   6. Anticholinergics
   7. Others

7. Market Segmentation – By Route of Administration

   1. Oral
   2. Injectable
   3. Others

8. Market Segmentation – By Distribution Channel

   1. Hospital Pharmacies
   2. Retail Pharmacies
   3. Online Pharmacies

9. Competitive Landscape

   1. Competitive Overview and Key Market Players
   2. Market Share Analysis and Positioning Matrix
   3. Strategic Partnerships, Mergers & Acquisitions
   4. Key Developments in Product Portfolios and Innovations
   5. Company Benchmarking

10. Company Profiles

11. Appendix

    1.  About Us and Services
    2. Contact Us